CML, or Chronic Myelogenous Leukemia, is a disease characterized by the bone marrow producing an excessive amount of white blood cells.
Understanding CML
Chronic myelogenous leukemia (CML), sometimes referred to as chronic granulocytic leukemia, is a slowly progressing blood and bone marrow disease. This condition generally develops during or after middle age, and it's rare in children. The core issue in CML is the uncontrolled production of white blood cells by the bone marrow.
Key aspects of CML
- Slow progression: Unlike acute forms of leukemia, CML advances gradually.
- Age-related: CML typically affects adults, especially those in middle age or older.
- Bone marrow disorder: The bone marrow is the primary site of the abnormality, producing too many white blood cells.
Impact of CML
The excessive production of white blood cells can lead to various health problems, as the abnormal cells can crowd out healthy blood cells.
Summary
In essence, CML is a blood and bone marrow disease where the bone marrow produces too many white blood cells, progressing slowly and commonly affecting adults.
